Actuarial Analysis of Survival among Breast Cancer Patients in Lithuania

Author:

Skučaitė Aldona,Puvačiauskienė Alma,Puišys Rokas,Šiaulys JonasORCID

Abstract

Breast cancer is the most common cause of mortality due to cancer for women both in Lithuania and worldwide. Chances of survival after diagnosis differ significantly depending on the stage of disease at the time of diagnosis. Extended term periods are required to estimate survival of, e.g., 15–20 years. Moreover, since mortality of the average population changes with time, estimates of survival of cancer patients derived after a long period of observation can become outdated and can be no longer used to estimate survival of patients who were diagnosed later. Therefore, it can be useful to construct analytic functions that describe survival probabilities. Shorter periods of observation can be enough for such construction. We used the data collected by the Lithuanian Cancer Registry for our analysis. We estimated the chances of survival for up to 5 years after patients were diagnosed with breast cancer in Lithuania. Then we found analytic survival functions which best fit the observed data. At the end of this paper, we provided some examples for applications and directions for further research. We used mainly the Kaplan–Meier method for our study.

Funder

Lietuvos Mokslo Taryba

Publisher

MDPI AG

Subject

Health Information Management,Health Informatics,Health Policy,Leadership and Management

Reference30 articles.

1. Cancer in Lithuania during 2012 (Lithuanian) [Vėžys Lietuvoje 2012 Metais]. Annual report of Lithuanian Cancer Registryhttps://www.nvi.lt/uploads/pdf/Vezio%20registras/Vezys_lietuvoje_2012.pdf

2. An Actuarial Analysis Shows That Offering Lung Cancer Screening As An Insurance Benefit Would Save Lives At Relatively Low Cost

3. A Multi-Year Look at the Cost Burden of Cancer Care. Milliman Research Reporthttps://www.milliman.com/en/insight/2017/a-multi-year-look-at-the-cost-burden-of-cancer-care

4. Survival in stage I-III breast cancer patiens by surgical treatment in a publicly funded health care system;Fisher;Ann. Oncol.,2015

5. Is breast cancer survival improving?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3